awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q59652447-9825E2A4-7893-4AF2-AF55-A2804A3C0F96
Q59652447-9825E2A4-7893-4AF2-AF55-A2804A3C0F96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59652447-9825E2A4-7893-4AF2-AF55-A2804A3C0F96
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase I
P50
Q59652447-9825E2A4-7893-4AF2-AF55-A2804A3C0F96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59652447-9825E2A4-7893-4AF2-AF55-A2804A3C0F96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72c6f589e74073b820c0a044afbb54971b82975b
P1545
6
http://www.w3.org/2001/XMLSchema#string
P50
Andreas Wicki